Table 5.
Univariate analysis of the correlation between clinicopathological parameters and disease-free survival time of patients with gastric cancer.
| Variable | Mean survival time (m) | 95% CI | Log-rank test | P |
|---|---|---|---|---|
| Gender | ||||
| Male | 42.675 | 37.864–47.487 | 0.026 | 0.873 |
| Female | 41.668 | 34.077–49.260 | ||
| Age at surgery (yeas) | ||||
| ≤60 | 44.413 | 38.562–50.265 | 0.624 | 0.430 |
| >60 | 40.824 | 35.209–46.439 | ||
| Size of primary tumor (cm) | ||||
| ≤5 | 41.283 | 35.785–46.781 | 0.274 | 0.601 |
| >5 | 43.781 | 37.813–49.748 | ||
| Borrmann type | ||||
| I+II type | 44.407 | 37.282–51.531 | 0.469 | 0.493 |
| III+IV type | 41.486 | 36.547–46.424 | ||
| Degree of differentiation | ||||
| Well/moderate | 48.799 | 43.077–54.521 | 7.959 | 0.005 |
| Poor and not | 37.144 | 31.616–42.671 | ||
| Histological type | ||||
| Adenocarcinoma | 41.130 | 36.762–45.499 | 1.961 | 0.161 |
| Others | 47.854 | 37.543–58.165 | ||
| Depth of invasion | ||||
| T1 | 69.250 | 64.582–73.918 | 28.117 | 0.000 |
| T2 | 62.579 | 54.201–70.958 | ||
| T3 | 42.457 | 34.491–50.423 | ||
| T4 | 39.473 | 33.659–45.287 | ||
| Lymph node metastasis | ||||
| N0 | 50.574 | 42.663–58.485 | 18.060 | 0.000 |
| N1 | 51.080 | 43.649–58.510 | ||
| N2 | 37.015 | 29.857–44.173 | ||
| N3 | 31.325 | 22.864–39.787 | ||
| TNM stage | ||||
| I | 70.429 | 67.577–73.280 | 45.520 | 0.000 |
| II | 46.928 | 40.568–53.289 | ||
| III | 39.531 | 33.837–45.225 | ||
| IV | 10.846 | 6.640–15.052 | ||
| Prdx 1 expression | ||||
| Low | 56.937 | 51.396–62.477 | 21.481 | 0.000 |
| High | 35.519 | 30.553–40.484 | ||
| E-Ca expression | ||||
| Low | 33.797 | 28.696–38.898 | 18.717 | 0.000 |
| High | 52.490 | 46.853–58.127 | ||